• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒肺炎继发急性呼吸衰竭采用羟氯喹/阿奇霉素治疗

Acute Respiratory Failure Secondary to COVID-19 Viral Pneumonia Managed With Hydroxychloroquine/Azithromycin Treatment.

作者信息

Ng Kenneth K, Ng Mitchell K, Zhyvotovska Angelina, Singh Sahib, Shevde Ketan

机构信息

Anesthesiology, State University of New York Downstate Medical Center, Brooklyn, USA.

Orthopaedic Surgery, Maimonides Medical Center, Brooklyn, USA.

出版信息

Cureus. 2020 May 25;12(5):e8268. doi: 10.7759/cureus.8268.

DOI:10.7759/cureus.8268
PMID:32596085
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7314365/
Abstract

A 74-year-old male was admitted to the Intensive Care Unit (ICU) at State University of New York (SUNY) Downstate Medical Center following acute respiratory failure secondary to coronavirus disease 2019 (COVID-19) viral pneumonia. The patient had significant comorbidities, including a history of lung and esophageal cancer status-post resection, cerebrovascular accident with neurological deficits, diabetes mellitus, hypertension, and peripheral vascular disease. The patient was in septic shock and respiratory failure on admission requiring intubation and mechanical ventilation. Computed tomography (CT) of the chest showed patchy bilateral opacities suspicious for viral pneumonia and the COVID-19 sputum sample sent to the New York Department of Health returned positive. This patient's comorbidities, along with his age, placed him in the highest risk of mortality for COVID-19. The patient was managed pharmacologically with hydroxychloroquine and azithromycin. By Day 5 of his admission, he improved significantly and was extubated and downgraded from the ICU to the medical floor, pending discharge. This case report provides anecdotal evidence for the effectiveness of the hydroxychloroquine and azithromycin combination currently being used across the nation to manage COVID-19, pending development of a definitive vaccine or antiviral treatment.

摘要

一名74岁男性因2019冠状病毒病(COVID-19)病毒性肺炎继发急性呼吸衰竭,被收入纽约州立大学下州医学中心重症监护病房(ICU)。该患者有多种严重合并症,包括肺癌和食管癌切除术后病史、伴有神经功能缺损的脑血管意外、糖尿病、高血压和外周血管疾病。患者入院时处于感染性休克和呼吸衰竭状态,需要插管和机械通气。胸部计算机断层扫描(CT)显示双侧斑片状混浊,怀疑为病毒性肺炎,送往纽约州卫生部的COVID-19痰液样本检测呈阳性。该患者的合并症以及年龄,使他处于COVID-19死亡风险最高的类别。患者接受了羟氯喹和阿奇霉素的药物治疗。入院第5天,他明显好转,拔除气管插管,从ICU转至普通病房,等待出院。本病例报告为目前在全国范围内用于治疗COVID-19的羟氯喹和阿奇霉素联合用药的有效性提供了实例证据,直至确定的疫苗或抗病毒治疗方法出现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82c0/7314365/4fb080e05df4/cureus-0012-00000008268-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82c0/7314365/b05bab74bc55/cureus-0012-00000008268-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82c0/7314365/fdbeb7758dee/cureus-0012-00000008268-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82c0/7314365/b88bea1519ed/cureus-0012-00000008268-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82c0/7314365/4fb080e05df4/cureus-0012-00000008268-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82c0/7314365/b05bab74bc55/cureus-0012-00000008268-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82c0/7314365/fdbeb7758dee/cureus-0012-00000008268-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82c0/7314365/b88bea1519ed/cureus-0012-00000008268-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82c0/7314365/4fb080e05df4/cureus-0012-00000008268-i04.jpg

相似文献

1
Acute Respiratory Failure Secondary to COVID-19 Viral Pneumonia Managed With Hydroxychloroquine/Azithromycin Treatment.新冠病毒肺炎继发急性呼吸衰竭采用羟氯喹/阿奇霉素治疗
Cureus. 2020 May 25;12(5):e8268. doi: 10.7759/cureus.8268.
2
A Case Report of Rapidly Lethal Acute Respiratory Distress Syndrome Secondary to Coronavirus Disease 2019 Viral Pneumonia.一例继发于2019冠状病毒病病毒性肺炎的快速致死性急性呼吸窘迫综合征病例报告。
Cureus. 2020 May 21;12(5):e8228. doi: 10.7759/cureus.8228.
3
Humidifier Use and Prone Positioning in a Patient with Severe COVID-19 Pneumonia and Endotracheal Tube Impaction Due to Highly Viscous Sputum.严重新型冠状病毒肺炎患者因高粘性痰液导致气管插管嵌塞时使用加湿器及采取俯卧位的情况
Cureus. 2020 Jun 15;12(6):e8626. doi: 10.7759/cureus.8626.
4
A Case of Severe Acute Pancreatitis Secondary to COVID-19 Infection in a 30-Year-Old Male Patient.一名30岁男性患者因新冠病毒感染继发重症急性胰腺炎病例
Cureus. 2020 Nov 26;12(11):e11718. doi: 10.7759/cureus.11718.
5
A Coronavirus Disease 2019 (COVID-19) Patient with Multifocal Pneumonia Treated with Hydroxychloroquine.一名使用羟氯喹治疗的新型冠状病毒肺炎(COVID-19)多灶性肺炎患者。
Cureus. 2020 Mar 30;12(3):e7473. doi: 10.7759/cureus.7473.
6
Weather the Cytokine Storm: A Report of Successful Management of a Colon Cancer Survivor and a Critically Ill Patient with COVID-19.抵御细胞因子风暴:一名结肠癌幸存者和一名新冠肺炎重症患者成功救治报告
Case Rep Oncol. 2020 Jun 29;13(2):754-759. doi: 10.1159/000509507. eCollection 2020 May-Aug.
7
COVID-19 Coinfection with in a Patient with Multiple Myeloma.一名多发性骨髓瘤患者合并 COVID-19 感染
Case Rep Infect Dis. 2021 Jan 15;2021:8840536. doi: 10.1155/2021/8840536. eCollection 2021.
8
A case of secondary tension pneumothorax in COVID-19 pneumonia in a patient with no prior history of lung disease.一名既往无肺部疾病史的新型冠状病毒肺炎患者发生继发性张力性气胸的病例。
SAGE Open Med Case Rep. 2020 Oct 17;8:2050313X20967504. doi: 10.1177/2050313X20967504. eCollection 2020.
9
Impaired mental health status following intensive care unit admission in a patient with COVID-19.一名新冠肺炎患者入住重症监护病房后心理健康状况受损。
Acute Med Surg. 2020 Sep 2;7(1):e562. doi: 10.1002/ams2.562. eCollection 2020 Jan-Dec.
10
Pulmonary Embolism in COVID-19 Pneumonia: An Overlapping Diagnosis or a Misdiagnosis?新型冠状病毒肺炎中的肺栓塞:是重叠诊断还是误诊?
J Cardiovasc Echogr. 2020 Apr-Jun;30(2):110-112. doi: 10.4103/jcecho.jcecho_43_20. Epub 2020 Aug 17.

引用本文的文献

1
COVID-19 Therapeutic Potential of Natural Products.天然产物在 COVID-19 治疗方面的潜力。
Int J Mol Sci. 2023 May 31;24(11):9589. doi: 10.3390/ijms24119589.
2
A disturbed balance between blood complement protective factors (FH, ApoE) and common pathway effectors (C5a, TCC) in acute COVID-19 and during convalesce.在急性 COVID-19 和恢复期,血液补体保护因子(FH、ApoE)与共同途径效应物(C5a、TCC)之间的平衡失调。
Sci Rep. 2022 Aug 11;12(1):13658. doi: 10.1038/s41598-022-17011-7.
3
Clinical Management of COVID-19: A Review of Pharmacological Treatment Options.

本文引用的文献

1
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.羟氯喹和阿奇霉素治疗 COVID-19:一项开放标签非随机临床试验的结果。
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
2
COVID-19: consider cytokine storm syndromes and immunosuppression.2019冠状病毒病:考虑细胞因子风暴综合征和免疫抑制。
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
3
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
新型冠状病毒肺炎的临床管理:药理学治疗选择综述
Pharmaceuticals (Basel). 2021 May 28;14(6):520. doi: 10.3390/ph14060520.
4
Hospital Course of a Man With Viral Pneumonia Caused by COVID-19.一名由新冠病毒引起的病毒性肺炎男性患者的住院病程
Cureus. 2020 Jul 18;12(7):e9261. doi: 10.7759/cureus.9261.
氯喹抗冠状病毒的抗病毒作用的新见解:对 COVID-19 有何期待?
Int J Antimicrob Agents. 2020 May;55(5):105938. doi: 10.1016/j.ijantimicag.2020.105938. Epub 2020 Mar 12.
4
Real estimates of mortality following COVID-19 infection.新冠病毒感染后死亡率的实际估计值。
Lancet Infect Dis. 2020 Jul;20(7):773. doi: 10.1016/S1473-3099(20)30195-X. Epub 2020 Mar 12.
5
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.突破:磷酸氯喹在临床研究中显示出对 COVID-19 相关肺炎的明显疗效。
Biosci Trends. 2020 Mar 16;14(1):72-73. doi: 10.5582/bst.2020.01047. Epub 2020 Feb 19.
6
Increased Incidence of Gastrointestinal Side Effects in Patients Taking Hydroxychloroquine: A Brand-related Issue?服用羟氯喹的患者胃肠道副作用发生率增加:这是一个与品牌相关的问题吗?
J Rheumatol. 2017 Mar;44(3):398. doi: 10.3899/jrheum.161063.
7
Effects of chloroquine on viral infections: an old drug against today's diseases?氯喹对病毒感染的影响:一种治疗当今疾病的老药?
Lancet Infect Dis. 2003 Nov;3(11):722-7. doi: 10.1016/s1473-3099(03)00806-5.